García-Viejo MA - Search Results

1

Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study.

Martinez E, Mocroft A, García-Viejo MA, Pérez-Cuevas JB, Blanco JL, Mallolas J, Bianchi L, Conget I, Blanch J, Phillips A, Gatell JM. Martinez E, et al. Lancet. 2001 Feb 24;357(9256):592-8. doi: 10.1016/S0140-6736(00)04056-3. Lancet. 2001. PMID: 11558485

2

Sonographic assessment of regional fat in HIV-1-infected people.

Martínez E, Bianchi L, García-Viejo MA, Bru C, Gatell JM. Martínez E, et al. Lancet. 2000 Oct 21;356(9239):1412-3. doi: 10.1016/S0140-6736(00)02850-6. Lancet. 2000. PMID: 11052589

3

Impact of switching from human immunodeficiency virus type 1 protease inhibitors to efavirenz in successfully treated adults with lipodystrophy.

Martínez E, García-Viejo MA, Blanco JL, Bianchi L, Buira E, Conget I, Casamitjana R, Mallolas J, Gatell JM. Martínez E, et al. Clin Infect Dis. 2000 Nov;31(5):1266-73. doi: 10.1086/317426. Epub 2000 Nov 6. Clin Infect Dis. 2000. PMID: 11073762 Clinical Trial.

4

Discontinuation of secondary prophylaxis for cryptococcal meningitis in HIV-infected patients responding to highly active antiretroviral therapy.

Martínez E, García-Viejo MA, Marcos MA, Pérez-Cuevas JB, Blanco JL, Mallolas J, Miró JM, Gatell JM. Martínez E, et al. AIDS. 2000 Nov 10;14(16):2615-7. doi: 10.1097/00002030-200011100-00029. AIDS. 2000. PMID: 11101078 No abstract available.

5

Dose-finding study of once-daily indinavir/ritonavir plus zidovudine and lamivudine in HIV-infected patients.

Mallolas J, Blanco JL, Sarasa M, Giner V, Martínez E, García-Viejo MA, Arnaiz JA, Cruceta A, Soy D, Tuset M, Soriano A, Codina C, Pumarola T, Carné X, Gatell JM. Mallolas J, et al. J Acquir Immune Defic Syndr. 2000 Nov 1;25(3):229-35. doi: 10.1097/00126334-200011010-00004. J Acquir Immune Defic Syndr. 2000. PMID: 11115953 Clinical Trial.

6

Lipodystrophy syndrome in patients with HIV infection: quality of life issues.

Martínez E, Garcia-Viejo MA, Blanch L, Gatell JM. Martínez E, et al. Drug Saf. 2001;24(3):157-66. doi: 10.2165/00002018-200124030-00001. Drug Saf. 2001. PMID: 11347720 Review.

7

Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapy.

Martínez E, Blanco JL, Arnaiz JA, Pérez-Cuevas JB, Mocroft A, Cruceta A, Marcos MA, Milinkovic A, García-Viejo MA, Mallolas J, Carné X, Phillips A, Gatell JM. Martínez E, et al. AIDS. 2001 Jul 6;15(10):1261-8. doi: 10.1097/00002030-200107060-00007. AIDS. 2001. PMID: 11426070

8

Strategies for treating HIV-related lipodystrophy.

García-Viejo MA, Ruíz M, Martínez E. García-Viejo MA, et al. Expert Opin Investig Drugs. 2001 Aug;10(8):1443-56. doi: 10.1517/13543784.10.8.1443. Expert Opin Investig Drugs. 2001. PMID: 11772261 Review.

9

Mitochondrial effects of antiretroviral therapies in asymptomatic patients.

López S, Miró O, Martínez E, Pedrol E, Rodríguez-Santiago B, Milinkovic A, Soler A, García-Viejo MA, Nunes V, Casademont J, Gatell JM, Cardellach F. López S, et al. Antivir Ther. 2004 Feb;9(1):47-55. Antivir Ther. 2004. PMID: 15040536

10

Preliminary data of a prospective study on neuropsychiatric side effects after initiation of efavirenz.

Blanch J, Martínez E, Rousaud A, Blanco JL, García-Viejo MA, Peri JM, Mallolas J, De Lazzari E, De Pablo J, Gatell JM. Blanch J, et al. J Acquir Immune Defic Syndr. 2001 Aug 1;27(4):336-43. doi: 10.1097/00126334-200108010-00003. J Acquir Immune Defic Syndr. 2001. PMID: 11468421

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters